Stryker Q2 2024: organic sales +9.0%, adj. EPS $2.81, raises FY guidance

STRYKER CORP

2024-Q2 EPS reported $4.19 revenue$10,665,000,000

Net sales $5.4B (+8.5% reported, +9.0% organic); MedSurg Neuro +9.7% organic, Ortho Spine +8.0% organic.
Reported EPS $2.14 (+10.9% YoY); adjusted EPS $2.81 (+10.6% YoY); adjusted op. margin 24.6% (+30 bps).
FY 2024 organic sales growth guidance raised to 9.0%-10.0%; adjusted EPS guidance $11.90-$12.10.
Adjusted net earnings $1,085M (+11.2%). Guided for modest FX headwind ($0.10-$0.15) on adjusted EPS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.